Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Tsung-Hsien Chuang, Ph.D.

The Burnham Institute for Medical Research # of Grants: 3

Grants

Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle 16) $246,467
Cancer Research Project Awards

Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle 16) $100,481
Cancer Research Project Awards

Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle 16) $415,463
Cancer Research Project Awards
Publications

NF-kappaB activation primes cells to a pro-inflammatory polarized response to a TLR7 activation.
Periodical: Biochemical Journal Index Medicus:
Authors: Lee J, Hayashi M, Lo JF, Fearns C, Chu WM, Luo Y, Xiang R, Chuang TH ART
Yr: 2009 Vol: Nbr: Abs: Pg:

B activation primes cells to a pro-inflammatory polarized response to a TLR7 agonist.
Periodical: Biochemical Journal Index Medicus:
Authors: Lee J, Hayashi M, Lo JF, Fearns C, Chu WM, ,Xiang R, Chuang TH ART
Yr: 2009 Vol: 421 Nbr: 2 Abs: Pg: 301-310

A five amino acids motif at the undefined region of TLR8 ectodomain is required for species-specific recognition of agonists.
Periodical: Molecular Immunology Index Medicus:
Authors: Liu J, Xu C, Hsu LC, Luo Y, Xiang R, Chuang TH ART
Yr: 2010 Vol: 47 Nbr: 5 Abs: Pg: 1083-1090